Clinical trial shows benefit to adding Avastin to neoadjuvant chemotherapy in breast cancer patients
Amid the controversy surrounding the Food and Drug Administration’s ruling that Avastin should no longer be used to treat metastatic breast cancer, a new multinational phase 3 clinical trial shows that Avastin significantly increased tumor response rates in breast cancer patients when given before surgery.
Communication with doctors is critical to early, accurate colorectal cancer diagnosis
Colorectal cancer (CRC) is the second leading cause of cancer death in the U.S., but if diagnosed early, patients have a five-year survival rate of 91 percent. In a study recently published in the journalPatient Education and Counseling, Laura A. Siminoff, Ph.D., and a team of researchers conducted in-depth interviews with 242 patients diagnosed with CRC in the six months preceding the study.
Discoveries in mitochondria open new field of cancer research
Researchers at Virginia Commonwealth University Massey Cancer Center have revealed novel mechanisms in mitochondria that have implications for cancer as well as many other age-related diseases such as Parkinson’s disease, heart disease and hypertension. This discovery has pioneered the formation of a whole new field within epigenetics research ripe with possibilities of developing future gene therapies to treat cancer and age-associated diseases.
New therapy for blood cancers developed
Clinical researchers at VCU Massey Cancer Center have successfully completed a phase 1 clinical trial evaluating a combination of the drugs Bortezomib and Alvocidib in patients with relapsed or refractory blood cancers, paving the way for a phase 2 clinical trial to test the safety and effectiveness of the new therapy.
Massey physicians recognized as Top Docs by Richmond Magazine
Physicians at Virginia Commonwealth University Massey Cancer Center were reported as “Top Docs” in Richmond Magazine’s April 2011 issue. Honored with this recognition were 24 of Massey’s doctors. These selections were the result of a survey that asked Richmond-area physicians whom they would recommend in a range of specialties. Several of Massey’s doctors appeared in more than one category.